ASNM 5th RISING PROFESSIONAL CHALLENGE

Background/Aims: Prostate cancer is the fourth most common malignancy worldwide and the third in men of old age (average 65 years) in Myanmar. Currently, serum PSA is the marker of choice with highest positive predictive value in prostate carcinoma. Regarding staging of the disease, ultrasonography, CT, MRI and 99mTc-MDP SPECT-CT bone scintigraphy are choices of investigations practicing in Myanmar. Because of the evidence-based, promising success of 68Ga-PSMA &177Lu-PSMA theranostics management of prostate cancer worldwide, we did 99mTc-PSMA-I+S &177 Lu-PSMA theranostics in Myanmar with the available facilities